Christian Hodneland

Christian Hodneland, Ph.D.

Managing Director, Biopharma

Chicago skyline

About Dr. Hodneland

Christian Hodneland is a managing director for William Blair based in the firm’s Chicago office. He joined William Blair's investment banking team in 2006. Prior to William Blair, he worked for Arsenal Medical, Surface Logix, and Merrill Lynch.

Board Membership

SAMDI Tech, Inc.

Notable Transactions

Not Disclosed

a portfolio company of AGIC Capital

has agreed to be acquired by

William Blair in conjunction with its Asian affiliate, BDA Partners acted as exclusive financial advisors to The Ritedose Corporation, an AGIC Capital portfolio company, in connection with its pending sale to Novo Holdings.

Read more
$200,000,025

Follow-on Offering

$230,000,000

has sold its consumer health assets to

William Blair acted as the exclusive financial advisor to Akorn, Inc. in connection with the pending sale of its Consumer Health business to Prestige Consumer Healthcare.

Read more
Not Disclosed

an affiliate of Nationwide Children's Hospital

has received an investment from

a subsidiary of Danaher

$516,000,000

has been acquired by

$287,500,036

Follow-on Offering

$185,000,000

Animal Health Division

has been acquired by

William Blair acted as the exclusive financial advisor to Perrigo Company plc (NYSE:PRGO), in connection with the pending sale of its animal health division to PetIQ, Inc. (NASDAQ:PETQ) for $185 million.

Read more
$1,200,000,000

has been acquired by

Not Disclosed

has been acquired by

$51,750,000

Initial Public Offering

Not Disclosed

has been acquired by

Not Disclosed

has been acquired by

Rigorous pursuit of your success. Every transaction. Every time.

Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.

More about investment banking at William Blair
Aerial view of highway interchange at night

Biopharma

The rapid and cost-effective development of innovative therapeutics and treatments is critical not just to public health, but to the functioning of society and economic activity. Leading drug developers, as well as their partners across the research, development, and manufacturing value chain, count on William Blair’s deep expertise in biopharma’s capital-raising and deal-making landscape.

More about our biopharma expertise
Petri dish

About William Blair

William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

William Blair Emblem
1935

Year William Blair was founded

Icon of three people
+1,850

Employees worldwide

Dollar sign icon
+131 billion

Client assets

Handshake icon
87 Years

Independent and employee-owned

Globe icon
20+

Offices worldwide

Checklist icon
+700

Companies under coverage

As of March 31, 2022
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

More about William Blair affiliated entities